RAPP Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. (RAPP) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC Quant | New | +82.4K | — | $3.4M | 0.0% | 60 |
| OrbiMed Advisors Growth Healthcare | New | +76.6K | — | $3.2M | 0.1% | 59 |
| RENAISSANCE TECHNOLOGIES LLC Quant | Sold Out | -9.7K | -100.0% | $404.2K | 0.0% | 58 |
| Soleus Capital Management Growth Healthcare | Sold Out | -10.0K | -100.0% | $416.7K | 0.0% | 57 |
| Woodline Partners LP Long/Short | New | +97.5K | — | $4.1M | 0.0% | 56 |
| Verition Fund Management Event Long/Short | Sold Out | -7.5K | -100.0% | $313.8K | 0.0% | 54 |
| Quadrature Capital Quant | New | +6.4K | — | $265.0K | 0.0% | 52 |
| Vestal Point Capital Growth Healthcare | Reduced | -706.2K | -49.2% | $29.4M | 0.7% | 50 |
| Aquatic Capital Management Quant | New | +2.1K | — | $88.0K | 0.0% | 48 |
| Engineers Gate Quant | New | +21.3K | — | $888.2K | 0.0% | 48 |
Most significant buyers
By move score, not size.
- CITADEL ADVISORS LLC
- OrbiMed Advisors
- Woodline Partners LP
- Quadrature Capital
- Aquatic Capital Management
Most significant sellers
By move score, not size.
- RENAISSANCE TECHNOLOGIES LLC
- Soleus Capital Management
- Verition Fund Management
- Vestal Point Capital
- Quantbot Technologies
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 1 | 82.4K | 0 | +82.4K | — | 0.0% | New | 60 |
| OrbiMed Advisors | 2 | 76.6K | 0 | +76.6K | — | 0.1% | New | 59 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 0 | 9.7K | -9.7K | -100.0% | 0.0% | Sold Out | 58 |
| Soleus Capital Management | 2 | 0 | 10.0K | -10.0K | -100.0% | 0.0% | Sold Out | 57 |
| Woodline Partners LP | 2 | 97.5K | 0 | +97.5K | — | 0.0% | New | 56 |
| Verition Fund Management | 2 | 0 | 7.5K | -7.5K | -100.0% | 0.0% | Sold Out | 54 |
| Quadrature Capital | 3 | 6.4K | 0 | +6.4K | — | 0.0% | New | 52 |
| Vestal Point Capital | 1 | 730.0K | 1.4M | -706.2K | -49.2% | 0.7% | Reduced | 50 |
| Aquatic Capital Management | 4 | 2.1K | 0 | +2.1K | — | 0.0% | New | 48 |
| Engineers Gate | 4 | 21.3K | 0 | +21.3K | — | 0.0% | New | 48 |
| Walleye Capital | 3 | 102.2K | 11.1K | +91.0K | +816.4% | 0.0% | Increased | 47 |
| Trexquant Investment | 3 | 53.9K | 21.0K | +33.0K | +157.0% | 0.0% | Increased | 47 |
| Quantbot Technologies | 4 | 0 | 6.5K | -6.5K | -100.0% | 0.0% | Sold Out | 45 |
| MILLENNIUM MANAGEMENT LLC | 2 | 154.9K | 319.6K | -164.6K | -51.5% | 0.0% | Reduced | 41 |
| Perceptive Advisors | 1 | 773.3K | 673.9K | +99.4K | +14.8% | 0.5% | Increased | 37 |
| D. E. Shaw & Co., Inc. | 1 | 214.8K | 175.4K | +39.4K | +22.4% | 0.0% | Increased | 34 |
| Y-Intercept | 4 | 19.2K | 35.8K | -16.6K | -46.4% | 0.0% | Reduced | 29 |
| TWO SIGMA INVESTMENTS, LP | 2 | 24.5K | 28.1K | -3.6K | -12.9% | 0.0% | Reduced | 29 |
| AQR Capital Management | 3 | 26.5K | 25.5K | +944 | +3.7% | 0.0% | Increased | 21 |
| Baker Bros. Advisors | 1 | 1.5M | 1.5M | 0 | +0.0% | 0.3% | Unchanged | 27 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2 | 150.0K | 150.0K | 0 | +0.0% | 0.0% | Unchanged | 20 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.